Market Update: Eli Lilly & Company (NYSE:LLY) – EXCLUSIVE-US insurers hold back Lilly’s death-defying diabetes drug

[Reuters – UK Focus] – NEW YORK, Oct (HKSE: 3366-OL.HK – news) 2 (Reuters) – America’s largest health insurers are urging doctors to stick with current standard treatments for diabetes instead of flocking . . . → Read More: Market Update: Eli Lilly & Company (NYSE:LLY) – EXCLUSIVE-US insurers hold back Lilly’s death-defying diabetes drug Similar Articles: Market Update: Eli Lilly & Company (NYSE:LLY) – Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial Market Update: Eli Lilly & Company (NYSE:LLY) – FDA asks panel to weigh benefit, risk of Lilly lung cancer drug Market Update (NYSE:LLY): Eli Lilly wins UK Alimta drug patent case on appeal